Seo D, So J, Kim J, Jung H, Jang I, Kim H
Sci Rep. 2024; 14(1):14649.
PMID: 38918552
PMC: 11199480.
DOI: 10.1038/s41598-024-65486-3.
Martin S, Schneider R
Front Neurol. 2023; 14:1190208.
PMID: 37885474
PMC: 10598461.
DOI: 10.3389/fneur.2023.1190208.
Pinarello C, Elmers J, Inojosa H, Beste C, Ziemssen T
Front Neurosci. 2023; 17:1231321.
PMID: 37869507
PMC: 10585158.
DOI: 10.3389/fnins.2023.1231321.
Woelfle T, Bourguignon L, Lorscheider J, Kappos L, Naegelin Y, Jutzeler C
J Med Internet Res. 2023; 25:e44428.
PMID: 37498655
PMC: 10415952.
DOI: 10.2196/44428.
Kontaxis S, Laporta E, Garcia E, Martinis M, Leocani L, Roselli L
Sensors (Basel). 2023; 23(13).
PMID: 37447866
PMC: 10346544.
DOI: 10.3390/s23136017.
Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis.
Kontaxis S, Laporta E, Garcia E, Guerrero A, Zabalza A, Matteo M
Front Physiol. 2023; 14:1145818.
PMID: 37089424
PMC: 10117218.
DOI: 10.3389/fphys.2023.1145818.
Feasibility and scalability of a fitness tracker study: Results from a longitudinal analysis of persons with multiple sclerosis.
Sieber C, Haag C, Polhemus A, Sylvester R, Kool J, Gonzenbach R
Front Digit Health. 2023; 5:1006932.
PMID: 36926468
PMC: 10012422.
DOI: 10.3389/fdgth.2023.1006932.
Pedometers and Accelerometers in Multiple Sclerosis: Current and New Applications.
Sasaki J, Bertochi G, Meneguci J, Motl R
Int J Environ Res Public Health. 2022; 19(18).
PMID: 36142112
PMC: 9517119.
DOI: 10.3390/ijerph191811839.
Fall Prediction Based on Instrumented Measures of Gait and Turning in Daily Life in People with Multiple Sclerosis.
Arpan I, Shah V, McNames J, Harker G, Carlson-Kuhta P, Spain R
Sensors (Basel). 2022; 22(16).
PMID: 36015700
PMC: 9415310.
DOI: 10.3390/s22165940.
Decentralised clinical trials in multiple sclerosis research.
Garjani A, Liu B, Allen C, Gunzler D, Gerry S, Planchon S
Mult Scler. 2022; 29(3):317-325.
PMID: 35735014
PMC: 9972228.
DOI: 10.1177/13524585221100401.
Sensor-based gait analyses of the six-minute walk test identify qualitative improvement in gait parameters of people with multiple sclerosis after rehabilitation.
Berg-Hansen P, Moen S, Austeng A, Gonzales V, Klyve T, Negard H
J Neurol. 2022; 269(7):3723-3734.
PMID: 35166925
PMC: 8853386.
DOI: 10.1007/s00415-022-10998-z.
Practice Effects of Mobile Tests of Cognition, Dexterity, and Mobility on Patients With Multiple Sclerosis: Data Analysis of a Smartphone-Based Observational Study.
Woelfle T, Pless S, Wiencierz A, Kappos L, Naegelin Y, Lorscheider J
J Med Internet Res. 2021; 23(11):e30394.
PMID: 34792480
PMC: 8663564.
DOI: 10.2196/30394.
Digital Endpoints: Definition, Benefits, and Current Barriers in Accelerating Development and Adoption.
Landers M, Dorsey R, Saria S
Digit Biomark. 2021; 5(3):216-223.
PMID: 34703976
PMC: 8490914.
DOI: 10.1159/000517885.
Robotic-Based Well-Being Monitoring and Coaching System for the Elderly in Their Daily Activities.
Calatrava-Nicolas F, Gutierrez-Maestro E, Bautista-Salinas D, Ortiz F, Gonzalez J, Vera-Repullo J
Sensors (Basel). 2021; 21(20).
PMID: 34696078
PMC: 8540718.
DOI: 10.3390/s21206865.
Telehealth in Multiple Sclerosis Clinical Care and Research.
Xiang X, Bernard J
Curr Neurol Neurosci Rep. 2021; 21(4):14.
PMID: 33646409
PMC: 7917521.
DOI: 10.1007/s11910-021-01103-4.
Does gait bout definition influence the ability to discriminate gait quality between people with and without multiple sclerosis during daily life?.
Shah V, McNames J, Harker G, Curtze C, Carlson-Kuhta P, Spain R
Gait Posture. 2020; 84:108-113.
PMID: 33302221
PMC: 7946343.
DOI: 10.1016/j.gaitpost.2020.11.024.
Biosensor vital sign detects multiple sclerosis progression.
Krysko K, Akhbardeh A, Arjona J, Nourbakhsh B, Waubant E, Gourraud P
Ann Clin Transl Neurol. 2020; 8(1):4-14.
PMID: 33211403
PMC: 7818086.
DOI: 10.1002/acn3.51187.
Rates, patterns, and correlates of fitness tracker use among older adults with multiple sclerosis.
Silveira S, Baird J, Motl R
Disabil Health J. 2020; 14(1):100966.
PMID: 32811785
PMC: 7769884.
DOI: 10.1016/j.dhjo.2020.100966.
Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis.
Chitnis T, Glanz B, Gonzalez C, Healy B, Saraceno T, Sattarnezhad N
NPJ Digit Med. 2019; 2:123.
PMID: 31840094
PMC: 6906296.
DOI: 10.1038/s41746-019-0197-7.
Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment.
Cohen J, Trojano M, Mowry E, Uitdehaag B, Reingold S, Marrie R
Mult Scler. 2019; 26(1):23-37.
PMID: 31778094
PMC: 6950891.
DOI: 10.1177/1352458519892555.